Logo image of ARQ

ARQ INC (ARQ) Stock Fundamental Analysis

NASDAQ:ARQ - US00770C1018 - Common Stock

7.08 USD
-0.12 (-1.67%)
Last: 9/5/2025, 8:00:01 PM
7.08 USD
0 (0%)
After Hours: 9/5/2025, 8:00:01 PM
Fundamental Rating

3

Overall ARQ gets a fundamental rating of 3 out of 10. We evaluated ARQ against 83 industry peers in the Chemicals industry. While ARQ seems to be doing ok healthwise, there are quite some concerns on its profitability. ARQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ARQ had negative earnings in the past year.
In the past year ARQ had a positive cash flow from operations.
In the past 5 years ARQ reported 4 times negative net income.
In multiple years ARQ reported negative operating cash flow during the last 5 years.
ARQ Yearly Net Income VS EBIT VS OCF VS FCFARQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.58%, ARQ is doing worse than 60.24% of the companies in the same industry.
ARQ's Return On Equity of -0.76% is in line compared to the rest of the industry. ARQ outperforms 45.78% of its industry peers.
ARQ's Return On Invested Capital of 0.53% is on the low side compared to the rest of the industry. ARQ is outperformed by 79.52% of its industry peers.
Industry RankSector Rank
ROA -0.58%
ROE -0.76%
ROIC 0.53%
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ARQ Yearly ROA, ROE, ROICARQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

ARQ's Operating Margin of 1.47% is on the low side compared to the rest of the industry. ARQ is outperformed by 75.90% of its industry peers.
The Gross Margin of ARQ (36.27%) is better than 75.90% of its industry peers.
ARQ's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.47%
PM (TTM) N/A
GM 36.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
ARQ Yearly Profit, Operating, Gross MarginsARQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

4

2. Health

2.1 Basic Checks

ARQ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ARQ has been increased compared to 1 year ago.
Compared to 5 years ago, ARQ has more shares outstanding
Compared to 1 year ago, ARQ has an improved debt to assets ratio.
ARQ Yearly Shares OutstandingARQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ARQ Yearly Total Debt VS Total AssetsARQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.45 indicates that ARQ is not in any danger for bankruptcy at the moment.
ARQ has a better Altman-Z score (3.45) than 81.93% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ARQ is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.13, ARQ belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 3.45
ROIC/WACC0.06
WACC8.96%
ARQ Yearly LT Debt VS Equity VS FCFARQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.10 indicates that ARQ should not have too much problems paying its short term obligations.
With a Current ratio value of 1.10, ARQ is not doing good in the industry: 89.16% of the companies in the same industry are doing better.
ARQ has a Quick Ratio of 1.10. This is a bad value and indicates that ARQ is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.65, ARQ is not doing good in the industry: 87.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.65
ARQ Yearly Current Assets VS Current LiabilitesARQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.67% over the past year.
ARQ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.96%.
ARQ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.22% yearly.
EPS 1Y (TTM)91.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%12.51%

3.2 Future

The Earnings Per Share is expected to grow by 63.64% on average over the next years. This is a very strong growth
Based on estimates for the next years, ARQ will show a quite strong growth in Revenue. The Revenue will grow by 17.79% on average per year.
EPS Next Y125.25%
EPS Next 2Y118.57%
EPS Next 3Y92.37%
EPS Next 5Y63.64%
Revenue Next Year12.75%
Revenue Next 2Y18.94%
Revenue Next 3Y19.28%
Revenue Next 5Y17.79%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARQ Yearly Revenue VS EstimatesARQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
ARQ Yearly EPS VS EstimatesARQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ARQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 23.17 indicates a rather expensive valuation of ARQ.
ARQ's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ARQ to the average of the S&P500 Index (22.69), we can say ARQ is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 23.17
ARQ Price Earnings VS Forward Price EarningsARQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARQ indicates a slightly more expensive valuation: ARQ is more expensive than 77.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.3
ARQ Per share dataARQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARQ's earnings are expected to grow with 92.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y118.57%
EPS Next 3Y92.37%

More info and screens

0

5. Dividend

5.1 Amount

ARQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQ INC

NASDAQ:ARQ (9/5/2025, 8:00:01 PM)

After market: 7.08 0 (0%)

7.08

-0.12 (-1.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners33.88%
Inst Owner ChangeN/A
Ins Owners18.8%
Ins Owner Change16.52%
Market Cap302.25M
Analysts82.22
Price Target10.91 (54.1%)
Short Float %5.93%
Short Ratio6.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.8%
Min EPS beat(2)-90.4%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)30.69%
Min EPS beat(4)-90.4%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)42.17%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.27%
Min Revenue beat(2)2.71%
Max Revenue beat(2)9.82%
Revenue beat(4)3
Avg Revenue beat(4)4.67%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)13.26%
Revenue beat(8)6
Avg Revenue beat(8)6.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.13%
PT rev (3m)12.63%
EPS NQ rev (1m)-21.05%
EPS NQ rev (3m)-53.85%
EPS NY rev (1m)-41.08%
EPS NY rev (3m)-38.89%
Revenue NQ rev (1m)1%
Revenue NQ rev (3m)-12.37%
Revenue NY rev (1m)3.48%
Revenue NY rev (3m)4.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.17
P/S 2.57
P/FCF N/A
P/OCF 39.64
P/B 1.39
P/tB 1.44
EV/EBITDA 26.3
EPS(TTM)-0.01
EYN/A
EPS(NY)0.31
Fwd EY4.32%
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)0.18
OCFY2.52%
SpS2.76
BVpS5.08
TBVpS4.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.58%
ROE -0.76%
ROCE 0.73%
ROIC 0.53%
ROICexc 0.55%
ROICexgc 0.56%
OM 1.47%
PM (TTM) N/A
GM 36.27%
FCFM N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 629.02%
Cap/Sales 52.86%
Interest Coverage 250
Cash Conversion 65.64%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.65
Altman-Z 3.45
F-Score4
WACC8.96%
ROIC/WACC0.06
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y125.25%
EPS Next 2Y118.57%
EPS Next 3Y92.37%
EPS Next 5Y63.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%12.51%
Revenue Next Year12.75%
Revenue Next 2Y18.94%
Revenue Next 3Y19.28%
Revenue Next 5Y17.79%
EBIT growth 1Y145.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year738.5%
EBIT Next 3Y183.71%
EBIT Next 5Y107.02%
FCF growth 1Y-16.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.31%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%